Penserra Capital Management LLC Makes New $454,000 Investment in Align Technology, Inc. $ALGN

Penserra Capital Management LLC acquired a new position in Align Technology, Inc. (NASDAQ:ALGN) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,629 shares of the medical equipment provider’s stock, valued at approximately $454,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ALGN. Ninety One UK Ltd raised its position in Align Technology by 18.3% in the third quarter. Ninety One UK Ltd now owns 2,267,192 shares of the medical equipment provider’s stock valued at $283,898,000 after purchasing an additional 350,883 shares during the period. Federated Hermes Inc. boosted its position in shares of Align Technology by 31.0% in the second quarter. Federated Hermes Inc. now owns 926,733 shares of the medical equipment provider’s stock worth $175,458,000 after buying an additional 219,219 shares during the period. Disciplined Growth Investors Inc. MN grew its stake in shares of Align Technology by 0.9% in the second quarter. Disciplined Growth Investors Inc. MN now owns 844,987 shares of the medical equipment provider’s stock valued at $159,981,000 after buying an additional 7,754 shares in the last quarter. Norges Bank purchased a new stake in shares of Align Technology during the 2nd quarter valued at about $155,297,000. Finally, Bank of America Corp DE lifted its position in Align Technology by 60.7% during the 2nd quarter. Bank of America Corp DE now owns 786,637 shares of the medical equipment provider’s stock worth $148,934,000 after acquiring an additional 297,117 shares in the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.

Key Align Technology News

Here are the key news stories impacting Align Technology this week:

Please show the positive items first, then the neutral items, and finally the negative items.
• Positive Sentiment: Q4 results beat consensus — EPS $3.29 vs $2.99 est and revenue $1.05B vs $1.03B; management highlighted strong demand for clear aligners which drove record Invisalign volumes, a primary driver of the stock rally. Align Technology beats fourth-quarter results estimates on dental products demand
• Positive Sentiment: Major analyst price-target increases from Leerink (to $225) and Mizuho (to $215) boost upside perception and reflect analyst model upgrades after the quarter. Leerink Partners adjusts Align Technology PT to $225 Mizuho adjusts price target on Align Technology to $215
• Positive Sentiment: CEO Joseph Hogan framed the macro/demand backdrop as more stable and cited rising teen and international demand — supportive commentary for forward growth expectations. The markets are ‘more stable than what we experienced in the past,’ says Align Technology CEO
• Neutral Sentiment: Company set a modest 2026 revenue growth target of 3%–4% and issued Q1 revenue guidance roughly in line with Street estimates — suggests steady but not accelerating top-line growth. Align Technology outlines 3-percent–4-percent revenue growth target for 2026
• Neutral Sentiment: Analyst ratings are mixed: Jefferies raised its PT to $185 but kept a “hold,” and Morgan Stanley moved its PT to $169 with an “equal weight” stance — shows divergence in conviction despite upgrades. Jefferies co adjusts Align Technology price target to $185 Morgan Stanley raises price target
• Negative Sentiment: Margins declined in the quarter — gross and operating margins fell despite the volume beat, a profitability headwind that could limit multiple expansion if trends persist. ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down

Align Technology Stock Performance

Shares of ALGN stock opened at $187.60 on Monday. The stock has a market capitalization of $13.46 billion, a price-to-earnings ratio of 33.14, a PEG ratio of 2.10 and a beta of 1.84. Align Technology, Inc. has a one year low of $122.00 and a one year high of $224.18. The company’s 50-day simple moving average is $163.26 and its 200-day simple moving average is $148.06.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.30. The firm had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Align Technology had a return on equity of 15.16% and a net margin of 10.17%.Align Technology’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.44 earnings per share. As a group, research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Evercore ISI raised their price target on shares of Align Technology from $180.00 to $200.00 and gave the company an “outperform” rating in a report on Thursday. Stifel Nicolaus lifted their price target on shares of Align Technology from $200.00 to $210.00 and gave the stock a “buy” rating in a research note on Thursday. Wall Street Zen raised shares of Align Technology from a “hold” rating to a “buy” rating in a research report on Saturday, January 3rd. Finally, Evercore lifted their target price on Align Technology from $180.00 to $200.00 and gave the stock an “outperform” rating in a research report on Thursday. Seven equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $195.92.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.